Association of Inflammatory Mediators with Mitochondrial DNA Variants in Geriatric COVID-19 Patients

COVID-19 remains a serious concern for elderly individuals with underlying comorbidities. SARS-CoV-2 can target and damage mitochondria, potentially leading to mutations in mitochondrial DNA (mtDNA). This study aimed to evaluate single nucleotide substitutions in mtDNA and analyze their correlation with inflammatory biomarkers in elderly COVID-19 patients. A total of 30 COVID-19 patients and 33 older adult controls without COVID-19 (aged over 65 years) were enrolled. mtDNA was extracted from buffy coat samples and sequenced using a chip -based resequencing system (MitoChip v2.0) which detects both homoplasmic and heteroplasmic mtDNA variants (40-60% heteroplasmy), and allows the assessment of lowlevel heteroplasmy (<10% heteroplasmy). Serum concentrations of IL -6, IFN-alpha, TNF-alpha and IL -10 were determined in patients by a high -sensitivity immunoassay. We found a higher burden of total heteroplasmic variants in COVID-19 patients compared to controls with a selective increment in ND1 and COIII genes. Lowlevel heteroplasmy was significantly elevated in COVID-19 patients, especially in genes of the respiratory complex I. Both heteroplasmic variant burden and low-level heteroplasmy were associated with increased levels of IL -6, TNF-alpha, and IFN-alpha. These findings suggest that SARS-CoV-2 may induce mtDNA mutations that are related to the degree of inflammation.